Navigating Your Path to Parenthood: Can You Take Ozempic If Trying to Get Pregnant?

Last reviewed: July 2, 2026

Last updated: July 2, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Weight management and fertility planning often intersect for people trying to conceive. Research shows that GLP-1 receptor agonists like semaglutide have not been extensively studied in pregnant populations, which means stopping the medication before conception is the standard clinical recommendation.

GLP-1 Medications and Pregnancy Planning: What the Evidence Shows

Ozempic (semaglutide) and similar GLP-1 drugs are not recommended during pregnancy because animal studies have shown potential effects on fetal development. The FDA classifies semaglutide as Category C for pregnancy, meaning risk cannot be ruled out. Most fertility specialists advise discontinuing GLP-1 therapy at least two months before attempting conception to allow the medication to clear your system completely.

Current clinical guidelines from reproductive endocrinology societies emphasize that stopping GLP-1 medications is a precautionary measure, not because proven harm has occurred in human pregnancies. However, the lack of extensive human safety data makes conservative approaches standard practice. Your obstetrician and weight management doctor should coordinate timing to ensure you stop the medication with appropriate medical supervision.

Weight Loss and Fertility: Why Management Matters Before Conception

Excess weight can reduce fertility rates in both men and women by affecting hormone levels, ovulation regularity, and sperm quality. Reaching a healthier weight before conception may improve your chances of getting pregnant naturally and reduce pregnancy complications. Starting weight management now, even if conception is months away, positions your body optimally for family planning.

GLP-1 therapy like semaglutide can help you lose 15-22% of body weight over 12-18 months when combined with lifestyle changes. If you're planning to try for a baby within the next year, beginning treatment now allows time for meaningful weight loss before discontinuing the medication. This approach maximizes fertility benefits while respecting medical safety guidelines.

Planning the Timeline: When to Stop Semaglutide Before Trying to Conceive

A typical recommended timeline involves stopping semaglutide 8-12 weeks (approximately 2-3 months) before attempting pregnancy. This washout period allows the medication to fully exit your body and hormone systems to stabilize. Discuss your specific timeline with your primary care doctor and reproductive endocrinologist to create a personalized stopping schedule.

PlexusDx compounded semaglutide injections ($189/mo start) can be used as part of a structured weight loss program leading up to your conception timeline. Your healthcare team can adjust your dose and stopping date based on your weight loss progress and fertility goals. Many patients achieve significant weight loss in 6-12 months, providing adequate time for medication washout before conception attempts.

Personalized Fertility and Weight Management with Precision Testing

Your genetic makeup influences how your body responds to weight loss medications and manages weight naturally. The PlexusDx Precision Peptide Genetic Test ($298) analyzes genetic variants including MC4R rs17782313 that affect appetite regulation and medication response. Understanding your genetic predispositions helps your doctor optimize your treatment plan before conception.

Some genetic variants associated with fertility challenges overlap with metabolic pathways that GLP-1 medications target. By identifying your specific peptide pathway profile across 14 pathways and 150+ genetic insights, PlexusDx helps you understand whether aggressive weight loss before conception may improve your fertility outcomes. This personalized approach ensures your weight management strategy aligns with your family planning goals.

Safe Access to GLP-1 Therapy: Compounded Medications for Your Timeline

PlexusDx provides compounded semaglutide injections from licensed 503A compounding pharmacies in all 50 states without requiring insurance. This accessibility means you can start treatment immediately to reach your fertility-optimized weight before stopping for conception. Your dose may need to go up during your treatment—your price won't, staying flat at $149/mo across all commitment tiers.

HSA and FSA accounts cover PlexusDx compounded semaglutide, making treatment cost-effective for fertility planning. Once you've achieved your target weight loss and completed your medication washout period, you'll be positioned to pursue conception with improved metabolic health. Your PlexusDx healthcare team coordinates with your fertility specialist to ensure seamless transition off therapy.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($298) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection is $189/mo month-to-month, or from $149/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $298 to personalize your protocol from day one.

Frequently Asked Questions

Can I take semaglutide while trying to get pregnant?

No, clinical guidelines recommend stopping semaglutide at least 2-3 months before attempting conception because the medication has not been extensively studied in pregnant populations. Work with your doctor to create a timeline that allows adequate weight loss before discontinuation and medication washout before conception attempts.

What does research say about GLP-1 drugs and pregnancy safety?

Animal studies suggest potential effects on fetal development, which is why semaglutide carries an FDA Category C pregnancy classification. Limited human data exists because these medications are relatively new and pregnant people were excluded from clinical trials. Healthcare providers use a precautionary approach and recommend stopping GLP-1 therapy before conception.

How much weight can I lose on semaglutide before stopping for pregnancy?

Clinical trials show semaglutide users lose 15-22% of body weight over 12-18 months with lifestyle changes. Starting treatment now gives you 6-12 months to achieve meaningful weight loss before discontinuing for your conception timeline. PlexusDx semaglutide injections are $189/mo month-to-month, or from $149/mo on the 6-month plan, making this preparation phase affordable.

Does stopping semaglutide cause weight regain before pregnancy?

Weight regain after stopping GLP-1 therapy is possible but manageable with sustained lifestyle changes learned during treatment. Your healthcare team should provide nutrition and exercise support during your medication washout period to stabilize your new weight. Continuing healthy habits you developed on semaglutide helps maintain fertility-supporting weight through conception attempts.

Can genetic testing help optimize my weight loss before trying to conceive?

Yes, the PlexusDx Precision Peptide Genetic Test ($298) analyzes genetic variants like GLP1R rs6923761 that influence appetite regulation and fertility-related metabolism. This testing reveals your unique peptide pathway profile across 150+ genetic insights, helping your doctor personalize your weight loss strategy for maximum fertility benefit before conception.

Related Reading

• What Determines If You Are A Morning Person Or A Night Owl
• Can You Avoid Diabetes If It Runs In Your Family
• Lifemd Ozempic
• Eden Ozempic

Pricing and availability current as of July 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.